Standard Expected Years of Life Lost Due to Malignant Neoplasms in Poland, 2000-2014

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2019 Dec 11

PMID 31817261

Citations 2

Authors

Malgorzata Pikala

Monika Burzynska

Irena Maniecka-Bryla

Affiliations

Soon will be listed here.

Abstract

The aim of the study was an analysis of mortality trends due to malignant neoplasms in Poland. The study material was a database, consisting of 1,367,364 death certificates of inhabitants of Poland who died during the period 2000-2014 due to malignant cancer. To calculate years of life lost, the SEYLL index (Standard Expected Years of Life Lost per living person) was applied. We also calculated AAPC (Average Annual Percentage Change). The SEYLL index (per 10,000 population) due to malignant neoplasms in Poland in males decreased from 586.3 in 2000 to 575.5 in 2014, whereas in females it increased from 398.6 in 2000 to 418.3 in 2014. The greatest number of lost years of life in 2014 was attributed to lung cancer (174.7 per 10,000 males and 77.3 per 10,000 females), breast cancer in females (64.5) and colorectal cancer in males (39.0). The most negative trends were observed for lung cancer in females (AAPC = 3.5%) and for colorectal cancer (AAPC = 1.8%) and prostate cancer (AAPC = 1.6%) in males. Many lost years could have been prevented by including a greater number of Polish inhabitants in screening examinations, mostly targeted at malignant neoplasm, whose incidence is closely connected with modifiable risk factors.

Citing Articles

Heterogeneous trends of premature mortalities in Japan: joinpoint regression analysis of years of life lost from 2011 to 2019.

Tsuboi S, Mine T, Fukushima T Dialogues Health. 2024; 1:100071.

PMID: 38515924 PMC: 10953931. DOI: 10.1016/j.dialog.2022.100071.

Mortality Trends Due to Skin Melanoma in Poland in the Years 2000-2020.

Dziankowska-Zaborszczyk E, Maniecka-Bryla I, Pikala M Int J Environ Res Public Health. 2022; 19(23).

PMID: 36498192 PMC: 9739595. DOI: 10.3390/ijerph192316118.

References

Pikala M, Maniecka-Bryla I . Years of life lost due to malignant neoplasms characterized by the highest mortality rate. Arch Med Sci. 2014; 10(5):999-1006. PMC: 4223125. DOI: 10.5114/aoms.2013.36237. View

Pikala M, Maniecka-Bryla I . Fifteen-year mortality trends in Poland analysed with the use of standard expected years of life lost, 2000-2014. Sci Rep. 2017; 7(1):8730. PMC: 5562698. DOI: 10.1038/s41598-017-09441-5. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Waskiewicz A, Szczesniewska D, Szostak-Wegierek D, Kwasniewska M, Pajak A, Stepaniak U . Are dietary habits of the Polish population consistent with the recommendations for prevention of cardiovascular disease? - WOBASZ II project. Kardiol Pol. 2016; 74(9):969-77. DOI: 10.5603/KP.a2016.0003. View

Choi K, Suh M . Screening for gastric cancer: the usefulness of endoscopy. Clin Endosc. 2014; 47(6):490-6. PMC: 4260095. DOI: 10.5946/ce.2014.47.6.490. View

Maniecka-Bryla I, Bryla M, Bryla P, Pikala M . The burden of premature mortality in Poland analysed with the use of standard expected years of life lost. BMC Public Health. 2015; 15:101. PMC: 4328237. DOI: 10.1186/s12889-015-1487-x. View

. Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations. Vaccine. 2017; 35(43):5753-5755. DOI: 10.1016/j.vaccine.2017.05.069. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1):5-29. DOI: 10.3322/caac.21254. View

Zatonski W, Przewozniak K, Sulkowska U, West R, Wojtyla A . Tobacco smoking in countries of the European Union. Ann Agric Environ Med. 2012; 19(2):181-92. View

10.

Wong M, Goggins W, Wang H, Fung F, Leung C, Wong S . Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol. 2016; 70(5):862-874. DOI: 10.1016/j.eururo.2016.05.043. View

11.

Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F . Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer. 2014; 50(7):1330-44. DOI: 10.1016/j.ejca.2014.01.029. View

12.

Pikala M, Burzyn Ska M, Pikala R, Bryla M, Maniecka-Bryla I . Educational inequalities in premature mortality in Poland, 2002-2011: a population-based cross-sectional study. BMJ Open. 2016; 6(9):e011501. PMC: 5051391. DOI: 10.1136/bmjopen-2016-011501. View

13.

Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E . Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013; 24(10):2657-2671. DOI: 10.1093/annonc/mdt301. View

14.

Rachtan J . Smoking, passive smoking and lung cancer cell types among women in Poland. Lung Cancer. 2002; 35(2):129-36. DOI: 10.1016/s0169-5002(01)00330-0. View

15.

DeSantis C, Siegel R, Bandi P, Jemal A . Breast cancer statistics, 2011. CA Cancer J Clin. 2011; 61(6):409-18. DOI: 10.3322/caac.20134. View

16.

Hashim D, Boffetta P, La Vecchia C, Rota M, Bertuccio P, Malvezzi M . The global decrease in cancer mortality: trends and disparities. Ann Oncol. 2016; 27(5):926-33. DOI: 10.1093/annonc/mdw027. View

17.

Godlewski D, Wojtys P, Antczak A . Predictions of cancer incidence in Wielkopolska in 2018. Contemp Oncol (Pozn). 2013; 16(1):38-43. PMC: 3687375. DOI: 10.5114/wo.2012.27335. View

18.

Zatonski W, Zatonski M, Przewozniak K . Health improvement in Poland is contingent on continued extensive tobacco control measures. Ann Agric Environ Med. 2013; 20(2):405-11. View

19.

Powles J, Zatonski W, Vander Hoorn S, Ezzati M . The contribution of leading diseases and risk factors to excess losses of healthy life in Eastern Europe: burden of disease study. BMC Public Health. 2005; 5:116. PMC: 1298310. DOI: 10.1186/1471-2458-5-116. View

20.

Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C . Trends and predictions to 2020 in breast cancer mortality in Europe. Breast. 2017; 36:89-95. DOI: 10.1016/j.breast.2017.06.003. View